220 related articles for article (PubMed ID: 36195860)
1. Development and validation of an MRI-based radiomic model for predicting overall survival in nasopharyngeal carcinoma patients with local residual tumors after intensity-modulated radiotherapy.
Jiang S; Han L; Liang L; Long L
BMC Med Imaging; 2022 Oct; 22(1):174. PubMed ID: 36195860
[TBL] [Abstract][Full Text] [Related]
2. Development of a Radiotherapy Localisation Computed Tomography-Based Radiomic Model for Predicting Survival in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy Following Induction Chemotherapy.
Li X; Chen H; Zhao F; Zheng Y; Pang H; Xiang L
Cancer Control; 2022; 29():10732748221076820. PubMed ID: 35271403
[TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
4. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
[TBL] [Abstract][Full Text] [Related]
5. Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment.
Bao D; Liu Z; Geng Y; Li L; Xu H; Zhang Y; Hu L; Zhao X; Zhao Y; Luo D
Cancer Imaging; 2022 Jan; 22(1):10. PubMed ID: 35090572
[TBL] [Abstract][Full Text] [Related]
6. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
7. Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancer.
Xu H; Wang A; Zhang C; Ren J; Zhou P; Liu J
BMC Med Imaging; 2023 May; 23(1):66. PubMed ID: 37254101
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
9. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
10. Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Wu S; Li H; Dong A; Tian L; Ruan G; Liu L; Shao Y
J Magn Reson Imaging; 2021 Sep; 54(3):854-865. PubMed ID: 33830573
[TBL] [Abstract][Full Text] [Related]
11. Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma.
Shen H; Wang Y; Liu D; Lv R; Huang Y; Peng C; Jiang S; Wang Y; He Y; Lan X; Huang H; Sun J; Zhang J
Front Oncol; 2020; 10():618. PubMed ID: 32477932
[No Abstract] [Full Text] [Related]
12. Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
Liu T; Dong D; Zhao X; Ou XM; Yi JL; Guan J; Zhang Y; Xiao-Fei L; Xie CM; Luo DH; Sun R; Chen QY; Xing L; Guo SS; Liu LT; Lin DF; Chen YZ; Lin JY; Luo MJ; Yan WB; He ML; Mao MY; Zhu MY; Chen WH; Shen BW; Wang SQ; Li HL; Zhong LZ; Hu CS; Wu DH; Mai HQ; Tian J; Tang LQ
BMC Med; 2023 Nov; 21(1):464. PubMed ID: 38012705
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Bao D; Zhao Y; Liu Z; Xu H; Zhang Y; Yuan M; Li L; Lin M; Zhao X; Luo D
Head Neck; 2022 Dec; 44(12):2842-2853. PubMed ID: 36161397
[TBL] [Abstract][Full Text] [Related]
14. Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy.
Fei Z; Xu T; Qiu X; Li M; Chen T; Li L; Huang C; Chen C
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2047-2055. PubMed ID: 33392660
[TBL] [Abstract][Full Text] [Related]
15. Radiomic analysis of MRI for prediction of response to induction chemotherapy in nasopharyngeal carcinoma patients.
Wang A; Xu H; Zhang C; Ren J; Liu J; Zhou P
Clin Radiol; 2023 Sep; 78(9):e644-e653. PubMed ID: 37331848
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
Yang Y; Wu J; Mai W; Li H
Contrast Media Mol Imaging; 2022; 2022():3417480. PubMed ID: 36226269
[TBL] [Abstract][Full Text] [Related]
17. A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Bao D; Zhao Y; Li L; Lin M; Zhu Z; Yuan M; Zhong H; Xu H; Zhao X; Luo D
Eur Radiol; 2022 Oct; 32(10):6910-6921. PubMed ID: 35639143
[TBL] [Abstract][Full Text] [Related]
18. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
[TBL] [Abstract][Full Text] [Related]
19. A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
Zhong LZ; Fang XL; Dong D; Peng H; Fang MJ; Huang CL; He BX; Lin L; Ma J; Tang LL; Tian J
Radiother Oncol; 2020 Oct; 151():1-9. PubMed ID: 32634460
[TBL] [Abstract][Full Text] [Related]
20. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization.
Zhong X; Li L; Jiang H; Yin J; Lu B; Han W; Li J; Zhang J
BMC Med Imaging; 2020 Sep; 20(1):104. PubMed ID: 32873238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
